19:28

Updates in the Systemic Treatment of Pleural Mesothelioma

HMP Education

22:58

Optimal Treatment for Elderly Patients with NSCLC

HMP Education

19:49

Targeting Angiogenesis in Lung Cancer

HMP Education

20:35

Maintenance Paradigm in Non-squamous NSCLC

HMP Education

22:10

First and Second Generation ALK Inhibitors for the Treatment of Lung Cancer

HMP Education

21:37

Strategies for Overcoming KRAS Mutations

HMP Education

18:41

Extreme Rare Mutations in Lung Cancer (ROS1, TRK, HER2): Treatment opportunities

HMP Education

21:09

Mechanisms of Resistance to EGFR TKI and New Treatment Strategies

HMP Education

18:33

Algorithm for Molecular Testing: What’s new

HMP Education

22:50

Challenges for the Pathologist in the Era of Personalized Medicine

HMP Education

20:15

Response Criteria and Kinetics with Immunocheckpoint Inhibitors

HMP Education

19:00

Biomarkers Predicting Clinical Activity of Immunocheckpoints

HMP Education

14:46

Debate: Optimal Approach for Stage I NSCLC - Surgery

HMP Education

19:24

Debate: Optimal Approach for Stage I NSCLC - SBRT

HMP Education

23:42

Current Status of Adjuvant Therapy for NSCLC

HMP Education

21:32

Using Endobronchial and other Techniques to Optimize Lung Cancer Diagnosis and Therapy

HMP Education

18:14

The New Proposals for a New TNM Classification for Lung Cancer

HMP Education

21:13

Diagnostics for Staging of Lung Cancer, Including Functional Imaging and Volumetric Assessment

HMP Education